K Pharma (4896) · InitiativeRestated
Strengthening Corporate Governance to Protect Investors and Enhance Corporate Value
First written in FY2024. 1 of 2 entries say "Restated". Latest entry: FY2025.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Continuous Strengthening of Corporate Governance and Internal Control SystemsA theme 968 companies write about · 4 as a headwind · 1068 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 185 companies compared. The sentences above are computed from all 185.Comparing 200 of the theme's 1074 threads.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「We regard strengthening corporate governance as an important management issue in order to conduct fair and transparent corporate activities aimed at sustainably enhancing corporate value and protecting investors.」
The company continues to strengthen governance to enhance corporate value and protect investors, including cooperation among the Board of Directors, Audit & Supervisory Board, internal audit and accounting auditor. - FY2024First statedAnnual report
「We regard strengthening corporate governance as an important management issue in order to conduct fair and transparent corporate activities aimed at sustainably enhancing corporate value and protecting investors.」
The company first identified strengthening corporate governance, including cooperation among the Board of Directors, Audit & Supervisory Board, accounting auditor, outside experts and internal audit, as an independent material issue.